Search
Halozyme Therapeutics Inc
HALOAdd to Watchlist
68.550USD
-0.020-0.03%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
8.13BMarket Cap
23.19P/E TTM
Halozyme Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Halozyme Therapeutics Inc is 9.02, ranking 54 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 23.19, which is 62.60% below the recent high of 37.71 and 49.92% above the recent low of 11.61.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
